Press F5 to reset the data table
The table below lists the high, low, median, and total number of patients newly registered on interventional therapeutic protocols in the 12-month reporting period starting from 2010 to recent year at NCI-Designated Clinical and Comprehensive Cancer Centers.
FY | Type of Center | Range | Newly Registered Patients | |
---|---|---|---|---|
2021 | 13 Clinical Centers | High | 6,124 | |
2021 | Low | 3,302 | ||
2021 | Median | 3,913 | ||
2021 | Subtotal | 42,104 | ||
2021 | 51 Comp Centers | High | 25,170 | |
2021 | Low | 519 | ||
2021 | Median | 5,427 | ||
2021 | Subtotal | 369,758 | ||
2021 | Total | 411,862 | ||
2020 | 13 Clinical Centers | High | 6,909 | |
2020 | Low | 1,757 | ||
2020 | Median | 4,213 | ||
2020 | Subtotal | 50,910 | ||
2020 | 51 Comp Centers | High | 20,697 | |
2020 | Low | 562 | ||
2020 | Median | 5,846 | ||
2020 | Subtotal | 358,202 | ||
2020 | Total | 409,112 | ||
2019 | 13 Clinical Centers | High | 4,893 | |
2019 | Low | 2,296 | ||
2019 | Median | 3,823 | ||
2019 | Subtotal | 44,772 | ||
2019 | 51 Comp Centers | High | 24,466 | |
2019 | Low | 545 | ||
2019 | Median | 5,383 | ||
2019 | Subtotal | 342,643 | ||
2019 | Total | 387,415 | ||
2018 | 14 Clinical Centers | High | 4,539 | |
2018 | Low | 2,271 | ||
2018 | Median | 3,625 | ||
2018 | Subtotal | 40,398 | ||
2018 | 49 Comp Centers | High | 22,567 | |
2018 | Low | 516 | ||
2018 | Median | 5,056 | ||
2018 | Subtotal | 322,342 | ||
2018 | Total | 362,740 | ||
2017 | 13 Clinical Centers | High | 4,581 | |
2017 | Low | 2,125 | ||
2017 | Median | 3,457 | ||
2017 | Subtotal | 34,061 | ||
2017 | 49 Comp Centers | High | 22,255 | |
2017 | Low | 503 | ||
2017 | Median | 4,809 | ||
2017 | Subtotal | 302,506 | ||
2017 | Total | 336,567 | ||
2016 | 15 Clinical Centers | High | 4,567 | |
2016 | Low | 1,965 | ||
2016 | Median | 3,538 | ||
2016 | Subtotal | 38,434 | ||
2016 | 47 Comp Centers | High | 21,575 | |
2016 | Low | 503 | ||
2016 | Median | 4,573 | ||
2016 | Subtotal | 293,609 | ||
2016 | Total | 332,043 | ||
2015 | 17 Clinical Centers | High | 7,550 | |
2015 | Low | 2,065 | ||
2015 | Median | 3,751 | ||
2015 | Subtotal | 61,714 | ||
2015 | 45 Comp Centers | High | 24,429 | |
2015 | Low | 488 | ||
2015 | Median | 4,701 | ||
2015 | Subtotal | 291,371 | ||
2015 | Total | 353,085 | ||
2014 | 20 Clinical Centers | High | 5,622 | |
2014 | Low | 1,638 | ||
2014 | Median | 3,360 | ||
2014 | Subtotal | 47,651 | ||
2014 | 41 Comp Centers | High | 24,537 | |
2014 | Low | 0 | ||
2014 | Median | 4,063 | ||
2014 | Subtotal | 269,861 | ||
2014 | Total | 317,512 | ||
2013 | 20 Clinical Centers | High | 7,208 | |
2013 | Low | 1,865 | ||
2013 | Median | 3,426 | ||
2013 | Subtotal | 75,235 | ||
2013 | 41 Comp Centers | High | 23,595 | |
2013 | Low | 290 | ||
2013 | Median | 4,201 | ||
2013 | Subtotal | 224,687 | ||
2013 | Total | 299,922 | ||
2012 | 19 Clinical Centers | High | 5,469 | |
2012 | Low | 1,846 | ||
2012 | Median | 2,973 | ||
2012 | Subtotal | 64,510 | ||
2012 | 41 Comp Centers | High | 23,595 | |
2012 | Low | 485 | ||
2012 | Median | 3,825 | ||
2012 | Subtotal | 230,085 | ||
2012 | Total | 294,595 | ||
2011 | 19 Clinical Centers | High | 6,916 | |
2011 | Low | 1,842 | ||
2011 | Median | 3,158 | ||
2011 | Subtotal | 63,478 | ||
2011 | 40 Comp Centers | High | 21,996 | |
2011 | Low | 451 | ||
2011 | Median | 3,786 | ||
2011 | Subtotal | 218,696 | ||
2011 | Total | 282,174 | ||
2010 | 19 Clinical Centers | High | 6,711 | |
2010 | Low | 1,842 | ||
2010 | Median | 2,922 | ||
2010 | Subtotal | 61,994 | ||
2010 | 40 Comp Centers | High | 21,350 | |
2010 | Low | 457 | ||
2010 | Median | 3,827 | ||
2010 | Subtotal | 212,132 | ||
2010 | Total | 274,126 |
The table below lists the top 20 anatomic cancer sites for newly registered patients in the 12-month reporting period starting from 2010 to recent year at NCI-designated Clinical and Comprehensive Cancer Centers.
FY | FY | Primary Site | Newly Registered Patients |
---|---|---|---|
2021 | Breast | 58,834 | |
2021 | Prostate | 44,389 | |
2021 | Lung | 35,495 | |
2021 | Melanoma, Skin | 23,549 | |
2021 | Non-Hodgkin Lymphoma | 17,129 | |
2021 | Lip, Oral Cavity and Pharynx | 16,137 | |
2021 | Colon | 15,689 | |
2021 | Kidney | 14,891 | |
2021 | Brain and Nervous System | 14,603 | |
2021 | Pancreas | 13,744 | |
2021 | Urinary Bladder | 13,406 | |
2021 | Corpus Uteri | 13,350 | |
2021 | Thyroid | 12,678 | |
2021 | Liver | 9,297 | |
2021 | Multiple Myeloma | 8,792 | |
2021 | Myeloid and Monocytic Leukemia | 8,655 | |
2021 | Rectum | 7,642 | |
2021 | Soft Tissue | 7,029 | |
2021 | Lymphoid Leukemia | 6,908 | |
2021 | Stomach | 5,763 | |
2020 | Breast | 58,183 | |
2020 | Prostate | 42,842 | |
2020 | Lung | 35,868 | |
2020 | Melanoma, Skin | 24,342 | |
2020 | Non-Hodgkin Lymphoma | 16,675 | |
2020 | Colon | 16,102 | |
2020 | Lip, Oral Cavity and Pharynx | 15,727 | |
2020 | Kidney | 14,984 | |
2020 | Brain and Nervous System | 14,719 | |
2020 | Pancreas | 13,526 | |
2020 | Corpus Uteri | 13,054 | |
2020 | Thyroid | 12,882 | |
2020 | Urinary Bladder | 12,381 | |
2020 | Liver | 9,823 | |
2020 | Multiple Myeloma | 9,547 | |
2020 | Myeloid and Monocytic Leukemia | 8,139 | |
2020 | Rectum | 7,930 | |
2020 | Lymphoid Leukemia | 7,285 | |
2020 | Soft Tissue | 6,661 | |
2020 | Stomach | 5,762 | |
2019 | Breast | 56,588 | |
2019 | Prostate | 39,611 | |
2019 | Lung | 34,977 | |
2019 | Melanoma, Skin | 23,706 | |
2019 | Non-Hodgkin Lymphoma | 15,484 | |
2019 | Colon | 15,220 | |
2019 | Lip, Oral Cavity and Pharynx | 14,248 | |
2019 | Brain and Nervous System | 13,819 | |
2019 | Kidney | 13,714 | |
2019 | Thyroid | 12,566 | |
2019 | Pancreas | 12,557 | |
2019 | Corpus Uteri | 11,984 | |
2019 | Urinary Bladder | 11,738 | |
2019 | Liver | 9,352 | |
2019 | Multiple Myeloma | 8,614 | |
2019 | Myeloid and Monocytic Leukemia | 7,932 | |
2019 | Rectum | 7,427 | |
2019 | Soft Tissue | 6,564 | |
2019 | Lymphoid Leukemia | 6,522 | |
2019 | Stomach | 5,619 | |
2018 | Breast | 50,642 | |
2018 | Prostate | 34,511 | |
2018 | Lung | 33,038 | |
2018 | Melanoma, Skin | 22,379 | |
2018 | Non-Hodgkin Lymphoma | 14,642 | |
2018 | Colon | 13,994 | |
2018 | Lip, Oral Cavity and Pharynx | 13,441 | |
2018 | Kidney | 12,966 | |
2018 | Brain and Nervous System | 12,881 | |
2018 | Pancreas | 12,139 | |
2018 | Thyroid | 11,717 | |
2018 | Corpus Uteri | 11,379 | |
2018 | Urinary Bladder | 11,319 | |
2018 | Liver | 9,454 | |
2018 | Multiple Myeloma | 7,821 | |
2018 | Rectum | 7,406 | |
2018 | Myeloid and Monocytic Leukemia | 7,306 | |
2018 | Soft Tissue | 6,649 | |
2018 | Lymphoid Leukemia | 6,573 | |
2018 | Stomach | 5,393 | |
2017 | Breast | 46,496 | |
2017 | Prostate | 30,787 | |
2017 | Lung | 30,747 | |
2017 | Melanoma, Skin | 21,066 | |
2017 | Colon | 13,030 | |
2017 | Non-Hodgkin Lymphoma | 12,996 | |
2017 | Brain and Nervous System | 12,464 | |
2017 | Lip, Oral Cavity and Pharynx | 12,407 | |
2017 | Kidney | 11,912 | |
2017 | Thyroid | 11,351 | |
2017 | Corpus Uteri | 11,114 | |
2017 | Pancreas | 10,401 | |
2017 | Urinary Bladder | 10,009 | |
2017 | Liver | 9,053 | |
2017 | Myeloid and Monocytic Leukemia | 7,169 | |
2017 | Multiple Myeloma | 7,061 | |
2017 | Rectum | 6,751 | |
2017 | Soft Tissue | 5,963 | |
2017 | Lymphoid Leukemia | 5,937 | |
2017 | Ovary | 5,058 | |
2016 | Breast | 45,540 | |
2016 | Lung | 30,534 | |
2016 | Prostate | 28,671 | |
2016 | Melanoma, Skin | 20,119 | |
2016 | Brain and Nervous System | 13,105 | |
2016 | Non-Hodgkin Lymphoma | 13,040 | |
2016 | Colon | 12,598 | |
2016 | Lip, Oral Cavity and Pharynx | 12,242 | |
2016 | Kidney | 12,110 | |
2016 | Thyroid | 11,799 | |
2016 | Pancreas | 11,021 | |
2016 | Corpus Uteri | 10,412 | |
2016 | Urinary Bladder | 10,196 | |
2016 | Liver | 8,774 | |
2016 | Myeloid and Monocytic Leukemia | 7,092 | |
2016 | Rectum | 6,873 | |
2016 | Multiple Myeloma | 6,800 | |
2016 | Soft Tissue | 5,955 | |
2016 | Lymphoid Leukemia | 5,592 | |
2016 | Stomach | 5,154 | |
2015 | Breast - Female | 48,962 | |
2015 | Lung | 32,900 | |
2015 | Prostate | 30,611 | |
2015 | Melanoma, Skin | 20,580 | |
2015 | Non-Hodgkin Lymphoma | 14,289 | |
2015 | Brain and Nervous System | 13,461 | |
2015 | Colon | 13,434 | |
2015 | Kidney | 13,300 | |
2015 | Lip, Oral Cavity and Pharynx | 13,046 | |
2015 | Thyroid | 12,864 | |
2015 | Pancreas | 11,918 | |
2015 | Corpus Uteri | 11,361 | |
2015 | Bladder | 10,664 | |
2015 | Liver | 9,123 | |
2015 | Rectum | 7,557 | |
2015 | Myeloid and Monocytic Leukemia | 7,521 | |
2015 | Multiple Myeloma | 7,010 | |
2015 | Soft Tissue | 6,322 | |
2015 | Lymphoid Leukemia | 5,882 | |
2015 | Ovary | 5,703 | |
2014 | Breast - Female | 44,130 | |
2014 | Lung | 28,775 | |
2014 | Prostate | 28,660 | |
2014 | Melanoma, Skin | 19,283 | |
2014 | Non-Hodgkin Lymphoma | 12,626 | |
2014 | Brain and Nervous System | 12,139 | |
2014 | Colon | 11,937 | |
2014 | Kidney | 11,707 | |
2014 | Thyroid | 11,640 | |
2014 | Lip, Oral Cavity and Pharynx | 11,598 | |
2014 | Pancreas | 10,432 | |
2014 | Corpus Uteri | 10,143 | |
2014 | Bladder | 9,807 | |
2014 | Liver | 7,948 | |
2014 | Myeloid and Monocytic Leukemia | 6,642 | |
2014 | Rectum | 6,529 | |
2014 | Multiple Myeloma | 6,190 | |
2014 | Soft Tissue | 5,775 | |
2014 | Lymphoid Leukemia | 5,251 | |
2014 | Ovary | 5,223 | |
2013 | Breast | 39,089 | |
2013 | Prostate | 29,778 | |
2013 | Lung | 26,477 | |
2013 | Melanoma, Skin | 18,552 | |
2013 | Non-Hodgkin Lymphoma | 12,029 | |
2013 | Brain and Nervous System | 11,515 | |
2013 | Lip, Oral Cavity and Pharynx | 11,475 | |
2013 | Colon | 11,344 | |
2013 | Kidney | 10,845 | |
2013 | Thyroid | 10,120 | |
2013 | Pancreas | 9,771 | |
2013 | Corpus Uteri | 9,221 | |
2013 | Bladder | 8,805 | |
2013 | Liver | 7,222 | |
2013 | Myeloid and Monocytic Leukemia | 6,046 | |
2013 | Rectum | 6,014 | |
2013 | Multiple Myeloma | 5,551 | |
2013 | Soft Tissue | 5,389 | |
2013 | Lymphoid Leukemia | 4,946 | |
2013 | Ovary | 4,877 | |
2012 | Breast – Female | 38,473 | |
2012 | Prostate | 31,414 | |
2012 | Lung | 26,168 | |
2012 | Melanoma, Skin | 17,587 | |
2012 | Non-Hodgkin Lymphoma | 11,875 | |
2012 | Brain and Nervous System | 11,786 | |
2012 | Colon | 11,409 | |
2012 | Lip, Oral Cavity and Pharynx | 10,762 | |
2012 | Kidney | 10,505 | |
2012 | Thyroid | 9,385 | |
2012 | Pancreas | 9,130 | |
2012 | Corpus Uteri | 8,977 | |
2012 | Bladder | 8,371 | |
2012 | Liver | 6,809 | |
2012 | Rectum | 6,189 | |
2012 | Myeloid and Monocytic Leukemia | 6,016 | |
2012 | Soft Tissue | 5,493 | |
2012 | Multiple Myeloma | 5,356 | |
2012 | Ovary | 5,123 | |
2012 | Lymphoid Leukemia | 4,976 | |
2011 | Breast - Female | 35,881 | |
2011 | Prostate | 28,817 | |
2011 | Lung | 24,386 | |
2011 | Melanoma, skin | 15,129 | |
2011 | Brain and Nervous System | 10,724 | |
2011 | Non-Hodgkin's Lymphoma | 10,620 | |
2011 | Colon | 10,584 | |
2011 | KIDNEY | 9,428 | |
2011 | Thyroid | 8,713 | |
2011 | Pancreas | 8,086 | |
2011 | Lip, Oral Cavity and Pharynx | 7,859 | |
2011 | Corpus Uteri | 6,252 | |
2011 | Urinary Bladder | 6,086 | |
2011 | Rectum | 5,500 | |
2011 | Liver | 5,490 | |
2011 | Soft Tissue | 4,990 | |
2011 | Myeloid and Monocytic Leukemia | 4,751 | |
2011 | Multiple Myeloma | 4,435 | |
2011 | Ovary | 4,429 | |
2011 | Stomach | 3,989 | |
2010 | Breast - Female | 36,367 | |
2010 | Prostate | 31,239 | |
2010 | Lung | 24,642 | |
2010 | Melanoma, skin | 15,857 | |
2010 | Brain and Nervous System | 11,074 | |
2010 | Colon | 10,975 | |
2010 | Non-Hodgkin’s Lymphoma | 10,459 | |
2010 | Lip, Oral Cavity and Pharynx | 9,577 | |
2010 | Kidney | 9,527 | |
2010 | Pancreas | 8,752 | |
2010 | Corpus Uteri | 8,258 | |
2010 | Thyroid | 8,227 | |
2010 | Bladder | 7,583 | |
2010 | Liver | 5,700 | |
2010 | Rectum | 5,456 | |
2010 | Soft Tissue | 5,238 | |
2010 | Myeloid and Monocytic Leukemia | 5,200 | |
2010 | Ovary | 4,853 | |
2010 | Lymphoid Leukemia | 4,379 | |
2010 | Esophagus | 4,027 |